| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656178 | HPB | 2017 | 9 Pages |
Abstract
PERT use was independently associated with improved survival following PD for cancer. The validity of this observation is supported by an effect largely confined to those patients with a dilated pancreatic duct. The nutritional status of patients undergoing PD for cancer needs further investigation and the effects of PERT require verification in further clinical studies.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Keith J. Roberts, Harald Schrem, James Hodson, Roberta Angelico, Bobby V.M. Dasari, Chris A. Coldham, Ravi Marudanayagam, Robert P. Sutcliffe, Paolo Muiesan, John Isaac, Darius F. Mirza,